STOCK TITAN

Bionano Genomics: CVI reports 9.9% warrant stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Bionano Genomics, Inc. (BNGO) is the issuer named in an amended Schedule 13G reporting a shared beneficial-ownership position of 1,499,332 shares, or 9.9% of the class, for CVI Investments, Inc. and its investment manager, Heights Capital Management, Inc. The reported shares are issuable upon exercise of warrants. Heights may exercise shared voting and dispositive power over the shares.

A portion of the warrants is not exercisable if aggregate beneficial ownership would exceed 4.99%; the remainder is not exercisable if it would exceed 9.99%. Bionano reported 13,509,000 shares outstanding as of September 30, 2026.

Reported beneficial ownership 1,499,332 shares Shared position reported by CVI Investments, Inc. and Heights Capital Management, Inc.; shares are issuable upon warrant exercise
Percentage of class 9.9% Reported beneficial ownership
Shares outstanding 13,509,000 shares As of September 30, 2026, according to Bionano's Quarterly Report on Form 10-Q
Warrant ownership limit 4.99% A portion of the warrants is not exercisable if aggregate beneficial ownership would exceed this level
Warrant ownership limit 9.99% The remainder of the warrants is not exercisable if aggregate beneficial ownership would exceed this level
Warrants financial
"shares issuable upon the exercise of warrants"
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.
beneficial ownership regulatory
"shares beneficially owned by each reporting person"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
shared voting power regulatory
"Shared Voting Power 1,499,332"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Section 13(d) of the Exchange Act regulatory
"aggregated with such Reporting Person for purposes of Section 13(d)"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many BNGO shares do CVI Investments and Heights Capital report?

They report a shared beneficial-ownership position of 1,499,332 shares, or 9.9% of the class. The reported shares are issuable upon exercise of warrants, and Heights Capital Management may exercise shared voting and dispositive power.

What ownership limits apply to the BNGO warrants?

A portion of the warrants is not exercisable if aggregate beneficial ownership would exceed 4.99%, while the remaining warrants are not exercisable if it would exceed 9.99%. The calculation includes affiliates and other persons whose ownership is aggregated under Section 13(d) of the Exchange Act.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





09075F404

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: With respect to Row 6 and Row 8 above, Heights Capital Management, Inc. is the investment manager to CVI Investments, Inc. and as such may exercise voting and dispositive power over the shares reported as beneficially owned by CVI Investments, Inc. herein.


SCHEDULE 13G




Comment for Type of Reporting Person: With respect to Row 6 and Row 8 above, Heights Capital Management, Inc. is the investment manager to CVI Investments, Inc. and as such may exercise voting and dispositive power over the shares reported as beneficially owned by CVI Investments, Inc. herein.


SCHEDULE 13G



CVI Investments, Inc.
Signature:/s/ Sarah Travis
Name/Title:Sarah Travis, Assistant General Counsel and Assistant Secretary of Heights Capital Management, Inc.
Date:11/12/2026
Heights Capital Management, Inc.
Signature:/s/ Sarah Travis
Name/Title:Sarah Travis, Assistant General Counsel and Assistant Secretary
Date:11/12/2026

Comments accompanying signature: Heights Capital Management, Inc. serves as authorized agent of CVI Investments, Inc. pursuant to a Limited Power of Attorney, a copy of which was previously filed.
Exhibit Information

EXHIBIT INDEX EXHIBIT DESCRIPTION 24 Limited Power of Attorney* 99 Joint Filing Agreement* * Previously filed

Keep reading